Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Solid Tumors Undergoing Surgery

Next Previous
Search
Trial Profile

A Phase 1 Exploratory Study of the Safety and ex Vivo Fluorescence of BLZ-100 Administered by Intravenous Injection in Adult Subjects With Solid Tumors Undergoing Surgery

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 17 Jul 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tozuleristide (Primary)
  • Indications Breast cancer; Solid tumours
  • Focus Adverse reactions
  • Sponsors Blaze Bioscience

    • Most Recent Events

    • 27 Apr 2017 Status changed from active, no longer recruiting to completed, as reported in a Blaze Bioscience media release.
    • 27 Apr 2017 According to a Blaze Bioscience media release, this study was conducted at University of Washington Medical Center under the direction of principal investigator David Byrd. This study was supported by a Small Business Innovation Research (SBIR) Phase II contract by the National Cancer Institute (NCI).
    • 27 Apr 2017 According to a Blaze Bioscience media release, data (n=23) from this trial will be presented at the 18th Annual American Society of Breast Surgeons (ASBrS) Meeting 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top